183 related articles for article (PubMed ID: 11723222)
21. mu-Opioid receptors inhibit dopamine-stimulated activity of type V adenylyl cyclase but enhance dopamine-stimulated activity of type VII adenylyl cyclase.
Yoshimura M; Ikeda H; Tabakoff B
Mol Pharmacol; 1996 Jul; 50(1):43-51. PubMed ID: 8700117
[TBL] [Abstract][Full Text] [Related]
22. Selective activation of Galphao by D2L dopamine receptors in NS20Y neuroblastoma cells.
Watts VJ; Wiens BL; Cumbay MG; Vu MN; Neve RL; Neve KA
J Neurosci; 1998 Nov; 18(21):8692-9. PubMed ID: 9786976
[TBL] [Abstract][Full Text] [Related]
23. Differentiation-induced alterations in cyclic AMP signaling in the Cath.a differentiated (CAD) neuronal cell line.
Johnston CA; Beazely MA; Bilodeau ML; Andrisani O; Watts VJ
J Neurochem; 2004 Mar; 88(6):1497-508. PubMed ID: 15009651
[TBL] [Abstract][Full Text] [Related]
24. Drug-induced sensitization of adenylyl cyclase: assay streamlining and miniaturization for small molecule and siRNA screening applications.
Conley JM; Brust TF; Xu R; Burris KD; Watts VJ
J Vis Exp; 2014 Jan; (83):e51218. PubMed ID: 24514897
[TBL] [Abstract][Full Text] [Related]
25. Activation of a novel PKC isoform synergistically enhances D2L dopamine receptor-mediated sensitization of adenylate cyclase type 6.
Beazely MA; Watts VJ
Cell Signal; 2005 May; 17(5):647-53. PubMed ID: 15683739
[TBL] [Abstract][Full Text] [Related]
26. Specific activation of adenylyl cyclase V by a purinergic agonist.
Pucéat M; Bony C; Jaconi M; Vassort G
FEBS Lett; 1998 Jul; 431(2):189-94. PubMed ID: 9708900
[TBL] [Abstract][Full Text] [Related]
27. Sensitization of neuronal A2A adenosine receptors after persistent D2 dopamine receptor activation.
Vortherms TA; Watts VJ
J Pharmacol Exp Ther; 2004 Jan; 308(1):221-7. PubMed ID: 14566008
[TBL] [Abstract][Full Text] [Related]
28. Regulation of adenylyl cyclase isozymes on acute and chronic activation of inhibitory receptors.
Nevo I; Avidor-Reiss T; Levy R; Bayewitch M; Heldman E; Vogel Z
Mol Pharmacol; 1998 Aug; 54(2):419-26. PubMed ID: 9687584
[TBL] [Abstract][Full Text] [Related]
29. Ser/ Thr residues at α3/β5 loop of Gαs are important in morphine-induced adenylyl cyclase sensitization but not mitogen-activated protein kinase phosphorylation.
Seyedabadi M; Ostad SN; Albert PR; Dehpour AR; Rahimian R; Ghazi-Khansari M; Ghahremani MH
FEBS J; 2012 Feb; 279(4):650-60. PubMed ID: 22177524
[TBL] [Abstract][Full Text] [Related]
30. Synergistic activation of the type I adenylyl cyclase by Ca2+ and Gs-coupled receptors in vivo.
Wayman GA; Impey S; Wu Z; Kindsvogel W; Prichard L; Storm DR
J Biol Chem; 1994 Oct; 269(41):25400-5. PubMed ID: 7929237
[TBL] [Abstract][Full Text] [Related]
31. Dopamine-D2S receptor inhibition of calcium influx, adenylyl cyclase, and mitogen-activated protein kinase in pituitary cells: distinct Galpha and Gbetagamma requirements.
Banihashemi B; Albert PR
Mol Endocrinol; 2002 Oct; 16(10):2393-404. PubMed ID: 12351703
[TBL] [Abstract][Full Text] [Related]
32. Molecular mechanisms of adenylyl cyclase desensitization in pregnant rat myometrium following in vivo administration of the beta-adrenergic agonist, isoproterenol.
Lécrivain JL; Cohen-Tannoudji J; Robin MT; Coudouel N; Legrand C; Maltier JP
Biol Reprod; 1998 Jul; 59(1):45-52. PubMed ID: 9674992
[TBL] [Abstract][Full Text] [Related]
33. Effects of forskolin on Kupffer cell production of interleukin-10 and tumor necrosis factor alpha differ from those of endogenous adenylyl cyclase activators: possible role for adenylyl cyclase 9.
Dahle MK; Myhre AE; Aasen AO; Wang JE
Infect Immun; 2005 Nov; 73(11):7290-6. PubMed ID: 16239525
[TBL] [Abstract][Full Text] [Related]
34. Antagonism of Dopamine Receptor 2 Long Affects Cannabinoid Receptor 1 Signaling in a Cell Culture Model of Striatal Medium Spiny Projection Neurons.
Bagher AM; Laprairie RB; Kelly ME; Denovan-Wright EM
Mol Pharmacol; 2016 Jun; 89(6):652-66. PubMed ID: 27053685
[TBL] [Abstract][Full Text] [Related]
35. Genome-Wide Small Interfering RNA Screening Reveals a Role for Cullin3-Really Interesting New Gene Ligase Signaling in Heterologous Sensitization of Adenylyl Cyclase.
Ding Z; Ejendal KFK; Soto-Velasquez M; Hayes MP; Santoro N; Larsen MJ; Watts VJ
J Pharmacol Exp Ther; 2020 Mar; 372(3):267-276. PubMed ID: 31857349
[TBL] [Abstract][Full Text] [Related]
36. A Novel CRISPR/Cas9-Based Cellular Model to Explore Adenylyl Cyclase and cAMP Signaling.
Soto-Velasquez M; Hayes MP; Alpsoy A; Dykhuizen EC; Watts VJ
Mol Pharmacol; 2018 Sep; 94(3):963-972. PubMed ID: 29950405
[TBL] [Abstract][Full Text] [Related]
37. Identification of a selective small-molecule inhibitor of type 1 adenylyl cyclase activity with analgesic properties.
Brust TF; Alongkronrusmee D; Soto-Velasquez M; Baldwin TA; Ye Z; Dai M; Dessauer CW; van Rijn RM; Watts VJ
Sci Signal; 2017 Feb; 10(467):. PubMed ID: 28223412
[TBL] [Abstract][Full Text] [Related]
38. Ontogeny of beta-adrenoceptor/adenylyl cyclase desensitization mechanisms: the role of neonatal innervation.
Slotkin TA; Saleh JL; Zhang J; Seidler FJ
Brain Res; 1996 Dec; 742(1-2):317-28. PubMed ID: 9117411
[TBL] [Abstract][Full Text] [Related]
39. Expression and modulation of 5-hydroxytryptamine1A receptors in P11 cells.
Hensler JG; Cervera LS; Miller HA; Corbitt J
J Pharmacol Exp Ther; 1996 Sep; 278(3):1138-45. PubMed ID: 8819496
[TBL] [Abstract][Full Text] [Related]
40. Dopamine D2 receptor inhibition of adenylyl cyclase is abolished by acute ethanol but restored after chronic ethanol exposure (tolerance).
Yao L; Asai K; Jiang Z; Ishii A; Fan P; Gordon AS; Diamond I
J Pharmacol Exp Ther; 2001 Aug; 298(2):833-9. PubMed ID: 11454949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
